Dr Raman Gangakhedkar, former head of epidemiology and communicable diseases at the Indian Council of Medical Research, has discounted the need for the fourth dose of COVID-19 vaccine given the current evidence about the coronavirus and its variants.
If a person has taken a third dose of the anti-COVID-19 vaccine, it means his T-cell immune response has been trained thrice, Dr Gangakhedkar said on the sidelines of a function on Tuesday.
"The core virus (of COVID-19) has not been changed so much that a new vaccine would be needed, so try and have trust in our T-cell immune response," he said.
"Looking at the current evidence (of variants of the virus), it is not that big that there is any need for the fourth dose of the COVID-19 vaccine. There are many reasons for that. Currently, whatever vaccines are there, the virus makes the escape mutants over them which causes infections," he said.
According to Dr Gangakhedkar, old people and those suffering from chronic morbidities should continue to take precautions such as wearing of masks.
"For the fourth dose, I think, there is still time to think, because if any new variant comes, it would not be from the SARS-COV2 family. It could be a completely new variant and when it comes, we will think about it as our genomic surveillance is still going on. No need to get worried now," he said.
Chronic Covid patients can trigger more lethal variants: WHO Study
Flu vaccine that can protect against all 20 known influenza virus developed
Covid lab leak theory is dead. The virus came from a Wuhan market: Report
Experts see 'a very hard road ahead' for China as Covid-19 cases spiral
Samples from Telangana's first suspected Monkeypox case sent to NIV
India reports 89 new Covid-19 infections, active cases below 2,000
Mumbai logs 4 new Covid-19 cases, zero death; active tally at 31
India records 94 new Covid-19 infections, active cases fall to 1,934
South Korea's cumulative Covid cases top 30 million; death toll at 33,235
Coronavirus has already infected 80% of our population, says China
Dr Gangakhedkar appealed to follow two things, including taking a precautionary dose and taking all the precautions for those who are in a vulnerable group.
He was speaking on the sidelines of a discussion on the book 'Braving a Viral Storm: India's COVID-19 Vaccine Story, organised by the Pune International Center.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)